AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 154 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $6,096,000 | -90.2% | 177,293 | -91.5% | 0.00% | -88.2% |
| Q3 2014 | $62,114,000 | +41.4% | 2,080,848 | -5.0% | 0.02% | +41.7% |
| Q2 2014 | $43,933,000 | -1.2% | 2,190,023 | +33.8% | 0.01% | 0.0% |
| Q1 2014 | $44,487,000 | +29.2% | 1,636,768 | -1.4% | 0.01% | +20.0% |
| Q4 2013 | $34,426,000 | +15.4% | 1,659,888 | +1.4% | 0.01% | +11.1% |
| Q3 2013 | $29,833,000 | +7.8% | 1,636,488 | -1.6% | 0.01% | 0.0% |
| Q2 2013 | $27,669,000 | – | 1,663,788 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,847,842 | $47,362,000 | 5.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,850,644 | $80,671,000 | 3.80% |
| KING INVESTMENT ADVISORS INC/TX | 491,465 | $8,174,000 | 3.39% |
| SECTOR GAMMA AS | 684,724 | $11,388,000 | 3.32% |
| Healthcare Value Capital, LLC | 274,481 | $4,565,000 | 3.31% |
| Broadfin Capital, LLC | 800,000 | $13,305,000 | 2.60% |
| Healthcare Value Capital, LLC | 150,000 | $2,495,000 | 1.81% |
| Artal Group S.A. | 2,637,200 | $43,859,000 | 1.38% |
| Proxima Capital Management, LLC | 355,722 | $5,916,000 | 1.37% |
| Manatuck Hill Partners, LLC | 414,000 | $6,885,000 | 0.84% |